Science
MD Anderson’s Therapeutics Discovery Division, Orionis Biosciences Launch Project Helios to Advance Novel Small-Molecule Cancer Medicines – Press Release – Digital Journal
Combining Orionis’ unique high-throughput drug discovery technologies with the Therapeutics Discovery division’s expertise in small-molecule therapies and translational…
BOSTON & GHENT, Belgium & HOUSTON–(Business Wire)–Orionis Biosciences, a life sciences company pioneering innovation in genome-scale drug discovery, and The University of Texas MD Anderson Cancer Centers Therapeutics Discovery division today announced the launch of Project Helios, a research collaboration designed to unlock new drug development opportunities through genome-scale mapping of drug-target interactions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210309005121/en/
…
-
Business16 hours agoBell Potter names the best ASX shares to buy in October
-
Noosa News14 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025
-
General13 hours agoAustralia welcomes Gaza peace progress, hostage release
-
Noosa News20 hours ago28 years later: Grim reality for single house hunters revealed